A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Saved in:
Bibliographic Details
Title: A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Authors: Layton JB; RTI Health Solutions, Research Triangle Park, North Carolina, USA., Anderson-Smits C; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Huang Z; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Ay H; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Spalding W; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Khokhar B; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Zhou J; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Bennett L; RTI Health Solutions, Research Triangle Park, North Carolina, USA., Anthony MS; RTI Health Solutions, Research Triangle Park, North Carolina, USA.
Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2025 Mar; Vol. 34 (3), pp. e70124.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1099-1557
DOI:10.1002/pds.70124